Santen

Important update to our followers! As part of our continuous efforts to enhance your experience and streamline our communications, we have some exciting news to share. Very soon our company pages Santen and Santen Pharmaceutical will be consolidated, forming a unified and stronger presence on LinkedIn. This means that after consolidation of these two accounts, the Santen Pharmaceutical account will cease to exist. The purpose of this change into one global account is to provide you with a consolidated and cohesive source of information about our company. We look forward to having you as part of our expanded community, so don’t forget to follow the new page, Santen, from December 2024. #Santen #Merge #Update #SantenCommunity

[Santen “Our Stories”] Santen Focusing on Global Eye Health Challenges   While eye health and vision are factors that can have a major impact on our day-to-day lives, increasingly millions of people around the world face severe challenges due to visual impairments.   This edition of “Our Stories” focuses on the importance of eye health and the current situation for people suffering from eye problems. Here are some of the featured key facts:   - There are approximately, 1 billion people with treatable and preventable visual impairments1. - It is assumed that 90% of blind people worldwide suffer vision loss due to refractive error, cataracts, or other causes that can be prevented or treated2. - Visual impairment poses a serious problem from a socio-economic perspective, with an estimated global annual productivity cost of US$411 billion3.   For the full story, please visit: Japanese article: https://lnkd.in/djwzFsYG. English article: https://lnkd.in/dmNQndqi.   References 1. WHO, World report on vision October 8, 2019 https://lnkd.in/dTZ8HwC. 2. Vision Atlas - The International Agency for the Prevention of Blindness (iapb.org) https://lnkd.in/ehQheQr. 3. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020.

‘Seeds of Medicine’ for Future Treatments: Santen’s Ophthalmic Innovation Center Building on its strong expertise in ophthalmology, Santen seeks to continue to deliver a broad range of treatment options through its therapeutics and services to address the unmet needs of patients and physicians. Currently, the company has a robust portfolio of more than 70 products covering an extensive range of ophthalmic diseases, while offering its products in more than 60 countries and regions. Santen’s Ophthalmology Innovation Center (OIC) is responsible for formulating and implementing disease area strategies that form the basis for the development of new drugs that support the product portfolio. “We are confident that our activities, guided by the desire to contribute to patients around the globe who suffer from eye problems, will make significant contributions to worldwide ophthalmic care in the future,” says Reza Haque, Head of the Ophthalmology Innovation Center. ‘Our Stories’ introduces OIC’s vision and the challenges it faces in pursuit of innovations that can meet the wide-ranging needs of patients suffering from eye diseases. Image features: Reza Haque, MD, Ph.D. Corporate Officer, Head, Ophthalmology Innovation Center

The Santen team is attending the International Council of Ophthalmology’s 39th World Ophthalmology Congress! Looking forward to connecting with others in the #Ophthalmology community to discuss all things #EyeCare.    #WOC2024 

[News] Santen Reports Q1 Fiscal 2024 Consolidated Performance. Financials: https://lnkd.in/gJYPpGKC Earnings Slides: https://lnkd.in/gMZfi_fT Santenは、2024年度の第1四半期決算発表を行いました。 決算短信: https://lnkd.in/gvBKsrxy 決算説明会資料: https://lnkd.in/g_k6j8X6

Our team is proud to have renewed our partnership with Orbis International for four consecutive years! This ongoing collaboration helps provide global access to the Flying Eye Hospital, a state-of-the-art teaching facility, operating room and recovery room, and Cybersight, a telemedicine platform for healthcare professionals. We are thrilled to continue our mission with Orbis International to realize “Happiness with Vision” for patients around the world. Learn more about Orbis below. https://www.orbis.org/en

Embracing our commitment to inclusion, we are excited to announce our corporate volunteering partnership with Be My Eyes on World Sight Day 2023 - an annual initiative led by the International Agency for the Prevention of Blindness (IAPB).   To champion this year’s theme on the importance of eye care in the workplace, Santen is joining hands with Be My Eyes to host a 72-hour event. Over three days, participating employees will volunteer to answer calls from persons with visual impairments within the global Be My Eyes network. This event marks a significant milestone as Santen becomes the first Japan-based global company to engage in Be My Eyes corporate volunteering events.   Learn more about Be My Eyes: bit.ly/3OP9Jrd and the theme of World Sight Day 2023: bit.ly/3LgEZyL   #WorldSightDay #LoveYourEyes #Accessiblity #Inclusion # SantenInspired